Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INFUSION, SOLUTION
INTRAVENOUS
Medical Information
J01MA14
moxifloxacin
Manufacturer Information
FRESENIUS KABI (SINGAPORE) PTE LTD
Fresenius Kabi Poland Sp. z.o.o